Pharmassent supports laboratories and biotech companies searching for collaboration with responsible manufacturers in France, and seeks professional relations with key people in the medical and pharmaceutical community. We promote dynamic venture synergy and partnership with top French biopharmaceutical manufacturers to help produce your ATMP (Advanced Therapy Medicinal Product) and comply with ATMP-MTI European regulation.
- Contract development and manufacturing organization (CDMO) activities
- Optimization and industrialization of processes
- GMP fabrication of cell and gene therapy products
- Recombinant proteins and monoclonal antibodies by cell culture manufacturing
- Production of plasma derivatives for third parties, governments or public corporations
- All types of autologous and/or allogeneic cell and gene therapy production
- Commercial manufacturing or clinical trials
- Logistics pharmaceutical distribution
- Specific regulatory services and post-authorisation vigilance systems
- Flexible facility design delivery for large-scale manufacture
Choose the right partner and take advantage of the largest European facility for GMP manufacturing of cell and gene therapy products.